For obesity without binge eating, the primary dysfunction appears to be impaired GLP-1 action, characterized by reduced satiety signaling and relatively rapid gastric emptying
Weeks 5-12 (dose escalation)
By prioritizing whole foods, staying mindful of portion size, scaling back on alcohol, and learning to embrace fitness, my weight loss journey has been a major success.
However, major expansion of the GLP-1 receptor agonist market in the US is fueled by heavy investments in research and development of new therapies by many pharmaceutical industries
Long-term treatment with palmitate, a type of long-chain saturated fatty acid, can disrupt the rhythmic secretion of GLP-1 by suppressing the expression of the Bmal1 clock gene [141]